UHMK1 and Miyoshi myopathy: By contrasting the MMDP sensitivities in HMCLs versus NHLCLs, we noted that 43% of the drugs had discernible differences in sensitivity between MM and lymphoma but the highest MM specificity was observed for signal transduction KIs.